Cyclic GMP act on :
**Core Concept**
Cyclic guanosine monophosphate (cGMP) is a key second messenger molecule involved in various cellular processes, including smooth muscle relaxation, platelet activation, and neurotransmission. cGMP acts as a downstream effector of nitric oxide (NO) signaling, playing a crucial role in vasodilation and other physiological responses.
**Why the Correct Answer is Right**
cGMP activates protein kinase G (PKG), a serine/threonine kinase that phosphorylates and thereby regulates the activity of various proteins. This includes the inhibition of smooth muscle contraction, platelet aggregation, and the regulation of ion channels. The activation of PKG by cGMP is a critical step in the NO signaling pathway, leading to vasodilation and other physiological effects.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because cGMP does not directly activate protein kinase A (PKA), which is activated by cyclic adenosine monophosphate (cAMP) instead.
**Option B:** This option is incorrect because cGMP does not directly interact with the adenylate cyclase enzyme, which is involved in the production of cAMP.
**Option C:** This option is incorrect because cGMP does not directly activate the phospholipase C (PLC) enzyme, which is involved in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG).
**Clinical Pearl / High-Yield Fact**
The NO-cGMP-PKG pathway is a key therapeutic target for the treatment of hypertension, with drugs such as nitroprusside and sildenafil (a phosphodiesterase-5 inhibitor) acting to increase cGMP levels and promote vasodilation.
**Correct Answer: D.**